266

Bioinformatics of the Brain

[25] E. Oveland, T. Muth, E. Rapp, et al., “Viewing the proteome: how to

visualize proteomics data?,” Proteomics, vol. 15, no. 8, pp. 1341–1355,

2015.

[26] H. Weisser and J. S. Choudhary, “Targeted feature detection for data-

dependent shotgun proteomics,” Journal of proteome research, vol. 16,

no. 8, pp. 2964–2974, 2017.

[27] J. P. Schessner, E. Voytik, and I. Bludau, “A practical guide to inter-

preting and generating bottom-up proteomics data visualizations,” Pro-

teomics, vol. 22, no. 8, p. 2100103, 2022.

[28] P. Sinitcyn, J. D. Rudolph, and J. Cox, “Computational methods for un-

derstanding mass spectrometry–based shotgun proteomics data,” Annual

Review of Biomedical Data Science, vol. 1, pp. 207–234, 2018.

[29] N. T. Doncheva, J. H. Morris, J. Gorodkin, et al., “Cytoscape stringapp:

network analysis and visualization of proteomics data,” Journal of pro-

teome research, vol. 18, no. 2, pp. 623–632, 2018.

[30] J. D. Rudolph and J. Cox, “A network module for the perseus software

for computational proteomics facilitates proteome interaction graph anal-

ysis,” Journal of proteome research, vol. 18, no. 5, pp. 2052–2064, 2019.

[31] L. Gatto, L. M. Breckels, T. Naake, et al., “Visualization of proteomics

data using r and bioconductor,” Proteomics, vol. 15, no. 8, pp. 1375–1389,

2015.

[32] H. Hampel, R. Nisticò, N. T. Seyfried, et al., “Omics sciences for systems

biology in alzheimer’s disease: State-of-the-art of the evidence,” Ageing

Research Reviews, vol. 69, p. 101346, 2021.

[33] S. Rayaprolu, L. Higginbotham, P. Bagchi, et al., “Systems-based pro-

teomics to resolve the biology of alzheimer’s disease beyond amyloid and

tau,” Neuropsychopharmacology, vol. 46, no. 1, pp. 98–115, 2021.

[34] A. M. Swomley and D. A. Butterfield, “Oxidative stress in alzheimer dis-

ease and mild cognitive impairment: evidence from human data provided

by redox proteomics,” Archives of toxicology, vol. 89, pp. 1669–1680, 2015.

[35] F. Di Domenico, E. Barone, M. Perluigi, et al., “The triangle of

death in alzheimer’s disease brain: the aberrant cross-talk among en-

ergy metabolism, mammalian target of rapamycin signaling, and protein

homeostasis revealed by redox proteomics,” Antioxidants & redox signal-

ing, vol. 26, no. 8, pp. 364–387, 2017.

[36] A. Tramutola, C. Lanzillotta, M. Perluigi, et al., “Oxidative stress, pro-

tein modification and alzheimer disease,” Brain research bulletin, vol. 133,

pp. 88–96, 2017.